Filing metadata

Accession number
0001266163-26-000002
Form type
Form 3
Filer
Enliven Therapeutics, Inc.
CIK
CIK 1672619
Filed
Oct 16, 2026
Reporting period
Oct 14, 2026
Description
Initial ownership

Explore SEC Filings Hub